A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.

Autor: Wilson B; Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Davison CL; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Lopez GH; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; School of Health, University of the Sunshine Coast, Sippy Downs, Queensland, Australia., Millard GM; Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Liew YW; Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Powley T; Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Campbell T; Carbal Medical Services, Toowoomba, Queensland, Australia., Jadhao SS; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia., Nagaraj SH; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Australia., Perry M; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Roulis EV; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia., Toombs M; School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Irving DO; Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Sydney, New South Wales, Australia.; Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Flower RL; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia., Hyland CA; Research and Development Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia.

Publikováno v: Transfusion [Transfusion] 2024 Jun; Vol. 64 (6), pp. 1171-1176. Date of Electronic Publication: 2024 Apr 30.

Hemolytic disease of the fetus and newborn caused by anti-s ^D antibody in a GP.Mur/Mur Thai mother and review of the prevalence of s ^D in Thai blood donors.

Autor: Lopez GH; Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; School of Health and Behavioural Sciences, University of the Sunshine Coast, Sippy Downs, Queensland, Australia., Emthip M; Red Cell Reference Laboratory, National Blood Centre, Thai Red Cross Society, Bangkok, Thailand., Suwanwootichai P; Red Cell Reference Laboratory, National Blood Centre, Thai Red Cross Society, Bangkok, Thailand., Millard GM; Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Red Cell Reference Laboratory, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Wilson B; Red Cell Reference Laboratory, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia., Onpuns S; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Laemsri K; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Chiewsilp P; Red Cell Reference Laboratory, National Blood Centre, Thai Red Cross Society, Bangkok, Thailand., Flower RL; Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Hyland CA; Research and Development, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Liew YW; Red Cell Reference Laboratory, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.

Publikováno v: Transfusion [Transfusion] 2022 Oct; Vol. 62 (10), pp. 2137-2142. Date of Electronic Publication: 2022 Sep 05.

Frequency of Mi ^a (MNS7) and Classification of Mi ^a -Positive Hybrid Glycophorins in an Australian Blood Donor Population.

Autor: Lopez GH; Research and Development Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia.; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia.; School of Medical Science, Griffith University, Gold Coast, Queensland, Australia., Wilson B; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Turner RM; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Millard GM; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Fraser NS; Research and Development Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Roots NM; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Liew YW; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Hyland CA; Research and Development Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia., Flower RL; Research and Development Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Kelvin Grove, Queensland, Australia.

Publikováno v: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie [Transfus Med Hemother] 2020 Jul; Vol. 47 (4), pp. 279-286. Date of Electronic Publication: 2019 Nov 14.

Investigation of the variable In(Lu) phenotype caused by KLF1 variants.

Autor: Fraser NS; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Knauth CM; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Schoeman EM; Research and Development, Australian Red Cross Blood Service., Moussa A; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Perkins AC; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia., Walsh T; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Millard GM; Research and Development, Australian Red Cross Blood Service., Dean MM; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Hyland CA; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Flower RL; Research and Development, Australian Red Cross Blood Service.; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia.

Publikováno v: Transfusion [Transfusion] 2018 Oct; Vol. 58 (10), pp. 2414-2420. Date of Electronic Publication: 2018 Sep 17.

A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms.

Autor: Lopez GH; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Turner RM; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., McGowan EC; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Schoeman EM; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Scott SA; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., O'Brien H; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Millard GM; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Roulis EV; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Allen AJ; Medical Services, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Liew YW; Red Cell Reference Laboratory, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Flower RL; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia., Hyland CA; Research and Development, Clinical Services and Research Division, Australian Red Cross Blood Service, Brisbane, Queensland, Australia.

Publikováno v: Transfusion [Transfusion] 2018 Mar; Vol. 58 (3), pp. 685-691. Date of Electronic Publication: 2017 Dec 06.